Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.79 |
| ▸ | CES1 | P23141 | 1/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | JAK1 | P23458 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547682 | 0.94 | CES2 (0.69) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL31032483 | 0.89 | CES2 (1.00) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL7220072 | 0.89 | CES2 (1.00) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL30161362 | 0.87 | CES2 (0.87) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL14876982 | 0.87 | CES2 (0.87) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL31474564 | 0.84 | CES2 (0.83) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| Beta-Naphtoic Acid SCHEMBL30678322 | 0.82 | CES2 (0.71) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| Beta-Naphtoic Acid SCHEMBL30678321 | 0.82 | CES2 (0.71) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| Beta-Naphtoic Acid SCHEMBL98296 | 0.82 | CES2 (0.71) | CES2CES1SMN1; SMN2MEN1KMT2A | |
| Beta-Naphtoic Acid SCHEMBL29628843 | 0.82 | CES2 (0.71) | CES2CES1SMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117844773-B | Phenylalanine dehydrogenase mutant and application thereof in synthesis of L-unnatural amino acid | 江南大学 | 2024-11-15 | — | — | CN | claimed |
| CN-117844773-A | Phenylalanine dehydrogenase mutant and application thereof in synthesis of L-unnatural amino acid | 江南大学 | 2024-04-09 | — | — | CN | claimed |
| CN-111978201-B | Synthesis method of N, N' -diaryl benzoyl hydrazine compound | 甘肃农业大学 | 2023-01-03 | — | — | CN | claimed |
| CN-111978201-A | Synthesis method of N, N' -diaryl benzoyl hydrazine compound | 甘肃农业大学 | 2020-11-24 | — | — | CN | claimed |
| CN-111056890-A | Method for preparing aryl ketone by free radical-free radical coupling reaction of ketoacid decarboxylation and fatty aldehyde decarbonylation based on iron catalysis | 湘潭大学 | 2020-04-24 | — | — | CN | claimed |
| CN-104961714-A | Synthetic method of alpha,beta-unsaturated butyrolactone | UNIV SOOCHOW | 2015-10-07 | — | — | CN | claimed |
| JP-2002514184-A | — | — | 2002-05-14 | — | — | JP | claimed |
| EP-1005348-A1 | NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS | GUILFORD PHARMACEUTICALS INC. (US) | 2000-06-07 | — | — | EP | claimed |
| WO-1998013046-A1 | NAALADASE COMPOSITIONS AND METHODS FOR TREATING GLUTAMATE ABNORMALITY AND EFFECTING NEURONAL ACTIVITY IN ANIMALS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-04-02 | — | — | WO | claimed |
| WO-2026100697-A1 | PHOTOCURABLE EPISULFIDE COMPOSITION, CURED PRODUCT, LAMINATE, AND METHOD FOR PRODUCING CURED PRODUCT | 三井化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| WO-2025068119-A1 | PHOTOINITIATORS FOR PHOTOCURABLE COMPOSITIONS | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-04-03 | — | — | WO | disclosed |
| WO-2025068116-A1 | PHOTOINITIATORS FOR PHOTOCURABLE COMPOSITIONS | COVESTRO (NETHERLANDS) B.V. (NL) | 2025-04-03 | — | — | WO | disclosed |
| CN-117844773-B | Phenylalanine dehydrogenase mutant and application thereof in synthesis of L-unnatural amino acid | 江南大学 | 2024-11-15 | — | — | CN | disclosed |
| CN-117844773-B | Phenylalanine dehydrogenase mutant and application thereof in synthesis of L-unnatural amino acid | 江南大学 | 2024-11-15 | — | — | CN | disclosed |
| WO-2007030967-A1 | 6-METHOXY-2,6-DIMETHYLOCTANAL AND ITS USE AS A FRAGRANCE INGREDIENT | GIVAUDAN SA (CH) | 2007-03-22 | — | — | WO | disclosed |
| EP-0057422-B1 | NEW CEPHEM COMPOUNDS, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-12 | — | — | EP | disclosed |
| EP-0191507-A2 | New 2-oxyimino-3-oxobutyric acid derivatives and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-08-20 | — | — | EP | disclosed |
| US-4562176-A | ANALOGS OF ACTINOMYCIN D | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1985-12-31 | — | — | US | disclosed |
| US-4452851-A | BACTERICIDES, ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-06-05 | — | — | US | disclosed |
| EP-0057422-A2 | New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1982-08-11 | — | — | EP | disclosed |